Home › Calculator › AXGN Dividend Calculator 2026
AXGN Dividend DRIP Calculator 2026
4.60% YieldHealthcareAxoGen, Inc. · NASDAQ
Price: $43.44 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When AXGN pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your AXGN snowball 📈
$10,000 in AXGN → $2.71M in 10 years · $40.79/month
About AxoGen, Inc. (AXGN) — Dividend Analysis 2026
AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating the gentle reconnection of severed peripheral nerves, the company offers the AxoGuard Nerve Connector, an extracellular matrix (ECM) derived from porcine submucosa. This same porcine submucosa ECM forms the basis of the AxoGuard Nerve Protector, which is utilized to encase and safeguard damaged peripheral nerves, supporting their reconstruction and preventing unwanted adhesions from surrounding soft tissues. Another ECM product, the AxoGuard Nerve Cap, isolates the nerve end from its environment to help mitigate the formation of painful neuromas. Furthermore, AxoGen provides the Avive Soft Tissue Membrane, a processed human umbilical cord membrane that functions as an absorbable covering for soft tissues, used to separate tissues within the surgical area. An additional tool available is the AxoTouch two-point discriminator, used for evaluating the density of nerve innervation on the skin's surface. These products are supplied to hospitals, surgery centers, and military medical facilities, catering to plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen's market reach extends across the United States, Canada, Germany, the United Kingdom, other European nations, South Korea, and internationally. The company's main operations are situated in Alachua, Florida.
Compare AXGN with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full AXGN DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open AXGN position with:
🌍 AXGN Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold AXGN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 4.60% | 1.80% | $460 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 3.91% | 1.11% | $391 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 3.68% | 0.88% | $368 / yr |
| 🇬🇧 UK ISA | 0% | 4.60% | 1.80% | $460 / yr |
| 🇬🇧 UK Taxable | 8.75% | 4.20% | 1.40% | $420 / yr |
| 🇨🇦 TFSA | 0% | 4.60% | 1.80% | $460 / yr |
| 🇨🇦 CA Taxable | 25% | 3.45% | 0.65% | $345 / yr |
| 🇦🇺 Super (pension) | 15% | 3.91% | 1.11% | $391 / yr |
| 🇦🇺 AU Taxable | 30% | 3.22% | 0.42% | $322 / yr |
| 🇩🇪 DE Taxable | 26.375% | 3.39% | 0.59% | $339 / yr |
| 🇫🇷 FR Taxable | 30% | 3.22% | 0.42% | $322 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 AXGN Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 AXGN Dividend Payment Schedule
AXGN pays quarterly — 4 times per year. Next ex-div: TBD.
📊 AXGN vs Healthcare Benchmarks
How AXGN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for AXGN sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ AXGN Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-24 | 4,392 | — | — | ||
| A-Award | 2026-06-24 | 4,392 | — | — | ||
| A-Award | 2026-06-24 | 4,392 | — | — | ||
| A-Award | 2026-06-24 | 5,579 | — | — | ||
| A-Award | 2026-06-24 | 4,392 | — | — | ||
| A-Award | 2026-06-24 | 4,392 | — | — | ||
| A-Award | 2026-06-24 | 4,392 | — | — | ||
| M-Exempt | 2026-06-19 | 14,150 | — | — | ||
| M-Exempt | 2026-06-19 | 14,150 | — | — | ||
| M-Exempt | 2026-06-19 | 14,150 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where AXGN earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the AXGN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
AxoGen, Inc. (AXGN) is currently trading at $43.44, trading near its 52-week high. The current dividend yield is 4.60% based on an annual payout of $2.00 per share.
AXGN (AxoGen, Inc.) — 4.60% Dividend Yield Analysis
AxoGen, Inc. (AXGN) is a healthcare stock currently trading at $43.44 with a dividend yield of 4.60%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.